National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

maytansinoid DM4-conjugated humanized monoclonal antibody huC242 (may-TAN-sih-noyd DM4-KON-juh-GAY-ted HYOO-muh-nized MAH-noh-KLOH-nul AN-tee-BAH-dee...)

 A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody locates and binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called huC242-DM4.



Previous Definitions:mature teratoma, matuzumab, Maxamine, maximum inspiratory pressure test, maximum tolerated dose
Next Definitions:MC1R, MDL 101,731, MDX-010, MDX-060, mean

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov